Gary Bridgman

Gary Bridgman

St. Jude Children's Research Hospital

Gary Bridgman is an enterprise content specialist in the Communications Department at St. Jude Children’s Research Hospital.

POSTS By Gary Bridgman

Staff scientists in core research facilities accelerate and broaden biomedical discovery

Staff scientists in core research facilities accelerate and broaden biomedical discovery

Posted by Gary Bridgman | Jul 14, 2020

These labs are highly specialized and deliver researchers access to advanced and speedy scientific results.

Learn more
Music therapy program goes digital to reach quarantined patients

Music therapy program goes digital to reach quarantined patients

Posted by Gary Bridgman | May 7, 2020

Read how this music therapist continues to help pediatric cancer patients with music therapy sessions even during quarantine.

Learn more
Ilaria Iacobucci Research Staff of the Year

Research Staff of the Year honoree Ilaria Iacobucci loves her work more than she misses Italy

Posted by Gary Bridgman | Jan 24, 2020

Staff scientist in Charles Mullighan’s pathology lab praised for new experimental approaches to leukemia pathogenesis and for helping others.

Learn more
Patenting ideas from bench to bedside

The agents of discovery: patenting and licensing ideas from bench to bedside

Posted by Gary Bridgman | Dec 12, 2019

Meet St. Jude’s tech transfer experts who patent and license researchers’ basic science discoveries to help patients worldwide.

Learn more
First Year of WHO Global Initiative for Childhood Cancer

Memphis to Myanmar: A Year in the life of the Global Initiative for Childhood Cancer

Posted by Gary Bridgman | Oct 1, 2019

Catherine Lam, MD, of St. Jude Global, has traveled around world to help low- and middle income countries improve children’s access to cancer care.

Learn more
SJELIOT clinical trial of children’s brain tumor therapy

SJELIOT clinical trial explores a new approach for recurring and unresponsive medulloblastoma tumors

Posted by Gary Bridgman | Jul 23, 2019

St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.

Learn more
Bioinformatics research scientist helps unlock elusive data

From evolutionary biology to immunology via bioinformatics

Posted by Gary Bridgman | May 1, 2019

Immunologists turn to Jeremy Crawford, PhD, when planning complex experiments or re-analyzing collected data. Learn about his bioinformatics career.

Learn more